The red pill or the blue pill? Presenting duality of choice; a choice between adapting or dying. Much like it, we pose a similar question, is it better to revive a legacy brand or build a new one from scratch? We explore this in our debate “Do or Do Not Resuscitate?” using the all new debate format ClickClock, where industry leaders go head-to-head trying to get their points across.
Seating is on first come, first served basis so please arrive on time as there is limited seating.
For those who cannot attend, the full debate will air on our page on October 2022.